Digestive Diseases and Sciences

, Volume 46, Issue 11, pp 2314–2321

Inhibition of β-Catenin Translocation in Rodent Colorectal Tumors: A Novel Explanation for the Protective Effect of Nonsteroidal Antiinflammatory Drugs in Colorectal Cancer


  • Wendy A. Brown
    • Monash University Department of SurgeryAlfred Hospital
  • Stewart A. Skinner
    • Monash University Department of SurgeryAlfred Hospital
  • Daphne Vogiagis
    • Monash University Department of SurgeryAlfred Hospital
  • Paul E. O'brien
    • Monash University Department of SurgeryAlfred Hospital

DOI: 10.1023/A:1012326525692

Cite this article as:
Brown, W.A., Skinner, S.A., Vogiagis, D. et al. Dig Dis Sci (2001) 46: 2314. doi:10.1023/A:1012326525692


In a rodent colorectal cancer model, nonsteroidal antiinflammatory drugs reduce tumor mass by increasing the rate of tumor cell apoptosis and decreasing proliferation. We have examined β-catenin as a potential target for these agents in colorectal cancer. Carcinogen-treated rats were treated for 23 weeks with a range of nonsteroidal antiinflammatory drugs. Control animals received vehicle alone. Intracellular β-catenin was examined using immunohistochemistry. In tumors from untreated animals, staining was seen in the cytoplasm and nucleus (median 24% of nucleii). The frequency of nuclear β-catenin staining correlated directly with the volume of tumor and inversely with the rate of apoptosis. In tumors from treatment groups, the cytoplasmic staining for β-catenin was unchanged; however, nuclear staining was absent except in the celecoxib group, where it was reduced to a median of 14%. Colorectal tumors from animals treated with NSAIDs show reduced levels of nuclear β-catenin immunoreactivity.

β-cateninnonsteroidal antiinflammatory drugscolorectal cancerimmunohistochemistryapoptosis
Download to read the full article text

Copyright information

© Plenum Publishing Corporation 2001